Đang chuẩn bị liên kết để tải về tài liệu:
Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6- methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
This investigator-initiated, open-label, single-arm, single-institute study was conducted to investigate the effectiveness of induction combination chemoradiotherapy and long-term maintenance therapy with temozolomide (TMZ) plus interferon (IFN)-β for glioblastoma. |